ZRO — BIOSENTA Share Price
0.000.00%
Last trade - 00:00- CA$5.07m
- CA$11.21m
- CA$0.00m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 25.25 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -686.06% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 0 | 0.17 | 0 | 0 | 0 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It also develops chemical compounds designed to eliminate harmful microorganisms, such as bacteria, fungi, and viruses for household and industrial uses, while ensuring safety for both humans and the environment. It offers true Disinfectant and Tri-Filler. The true disinfectant is recognized by Health Canada for use in the fight against COVID-19. Its true technology leads the charge against the threat of superbug pathogens. The Tri-Filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-Filler are embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain to protect the drywall of buildings, objects, such as resin furniture, resin, textiles and others.
Directors
- Last Annual
- September 30th, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- August 20th, 1986
- Public Since
- September 22nd, 2005
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 33,831,388
- Address
- 18 Wynford Drive, Suite 704, TORONTO, M3C 3S2
- Web
- https://www.biosenta.com
- Phone
- +1 4164102019
- Auditors
- MS Partners LLP
Upcoming Events for ZRO
Similar to ZRO
CleanGo Innovations
Canadian Securities Exchange
Ovation Science
Canadian Securities Exchange
FAQ
What is the BIOSENTA share price?
As of Today at 19:37 UTC, shares in BIOSENTA are trading at CA$0.15. This share price information is delayed by 15 minutes.
How has the BIOSENTA share price performed this year?
Shares in BIOSENTA last closed at CA$0.15 and the price had moved by -63.41% over the past 365 days. In terms of relative price strength the BIOSENTA share price has underperformed the Toronto Stock Exchange 300 Composite Index by -69.3% over the past year.
What are the analyst and broker recommendations for BIOSENTA?
There is no consensus recommendation for this security.
Find out moreWhat is the BIOSENTA dividend yield?
BIOSENTA does not currently pay a dividend.
Does BIOSENTA pay a dividend?
BIOSENTA does not currently pay a dividend.
When does BIOSENTA next pay dividends?
BIOSENTA does not currently pay a dividend.
How do I buy BIOSENTA shares?
To buy shares in BIOSENTA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BIOSENTA?
As of the previous close price of CA$0.15, shares in BIOSENTA had a market capitalisation of CA$5.07m.
Where are BIOSENTA shares listed?
Here are the trading details for BIOSENTA:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: ZRO
What kind of share is BIOSENTA?
Based on an overall assessment of its quality, value and momentum BIOSENTA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BIOSENTA share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the BIOSENTA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BIOSENTA. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -31.9%.
As of the last closing price of CA$0.15, shares in BIOSENTA were trading -32.84% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BIOSENTA PE Ratio?
The BIOSENTA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BIOSENTA?
We do not have data on BIOSENTA's directors